Related Experiment Video
Updated: May 19, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications
Katey S S Enfield1, Larissa A Pikor, Victor D Martinez
1British Columbia Cancer Research Center, Vancouver, BC, Canada V5Z 1L3.
Abstract:
Lung cancer biology has traditionally focused on genomic and epigenomic deregulation of protein-coding genes to identify oncogenes and tumor suppressors diagnostic and therapeutic targets. Another important layer of cancer biology has emerged in the form of noncoding RNAs (ncRNAs), which are major regulators of key cellular processes such as proliferation, RNA splicing, gene regulation, and apoptosis. In the past decade, microRNAs (miRNAs) have moved to the forefront of ncRNA cancer research, while the role of long noncoding RNAs (lncRNAs) is emerging. Here we review the mechanisms by which miRNAs and lncRNAs are deregulated in lung cancer, the technologies that can be applied to detect such alterations, and the clinical potential of these RNA species. An improved comprehension of lung cancer biology will come through the understanding of the interplay between deregulation of non-coding RNAs, the protein-coding genes they regulate, and how these interactions influence cellular networks and signalling pathways.
Insights
Noncoding RNAs (ncRNAs), including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), play crucial roles in lung cancer. Understanding their deregulation and interactions with protein-coding genes is key for new diagnostics and therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Traditional lung cancer research focused on protein-coding genes.
- Noncoding RNAs (ncRNAs) are critical regulators of cellular processes like proliferation and apoptosis.
- MicroRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
Purpose of the Study:
- To review the deregulation mechanisms of miRNAs and lncRNAs in lung cancer.
- To discuss technologies for detecting these RNA alterations.
- To explore the clinical potential of ncRNAs in lung cancer treatment.
Main Methods:
- Literature review of ncRNA deregulation in lung cancer.
- Analysis of current technologies for ncRNA detection.
- Evaluation of clinical applications and future directions for ncRNAs.
Main Results:
- ncRNAs are significantly deregulated in lung cancer, impacting key cellular functions.
- Various technologies exist for detecting miRNA and lncRNA alterations.
- ncRNAs show promise as diagnostic biomarkers and therapeutic targets.
Conclusions:
- Understanding ncRNA-protein-coding gene interactions is crucial for advancing lung cancer biology.
- ncRNAs represent a vital area for developing novel lung cancer diagnostics and therapeutics.
- Further research into the interplay of ncRNAs and cellular networks will improve lung cancer treatment strategies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Abnormal Proliferation
MicroRNAs